Literature DB >> 10413505

Shutoff and agonist-triggered internalization of protease-activated receptor 1 can be separated by mutation of putative phosphorylation sites in the cytoplasmic tail.

S R Hammes1, M J Shapiro, S R Coughlin.   

Abstract

The thrombin receptor PAR1 becomes rapidly phosphorylated upon activation by either thrombin or exogenous SFLLRN agonist peptide. Substitution of alanine for all serine and threonine residues in the receptor's cytoplasmic carboxyl-terminal tail ablated phosphorylation and yielded a receptor defective in both shutoff and agonist-triggered internalization. These observations suggested that activation-dependent phosphorylation of PAR1's cytoplasmic tail is required for both shutoff and agonist-triggered internalization. To identify the phosphorylation site(s) that are necessary for these functions, we generated three mutant receptors in which alanine was substituted for serine and threonine residues in the amino-terminal, middle, and carboxyl-terminal thirds of PAR1's cytoplasmic tail. When stably expressed in fibroblasts, all three mutated receptors were rapidly phosphorylated in response to agonist, while a mutant in which all serines and threonines in the cytoplasmic tail were converted to alanines was not. This result suggests that phosphorylation can occur at multiple sites in PAR1's cytoplasmic tail. Alanine substitutions in the N-terminal and C-terminal portions of the tail had no effect on either receptor shutoff or agonist-triggered internalization. By contrast, alanine substitutions in the "middle" serine cluster between Ser(391) and Ser(406) yielded a receptor with considerably slower shutoff of signaling after thrombin activation than the wild type. Surprisingly, this same mutant was indistinguishable from the wild type in agonist-triggered internalization and degradation. Overexpression of G protein-coupled receptor kinase 2 (GRK2) and GRK3 "suppressed" the shutoff defect of the S --> A (391-406) mutant, consistent with this defect being due to altered receptor phosphorylation. These results suggest that specific phosphorylation sites are required for rapid receptor shutoff, but phosphorylation at multiple alternative sites is sufficient for agonist-triggered internalization. The observation that internalization and acute shutoff were dissociated by mutation of PAR1 suggests that there are quantitative or qualitative differences in the requirements or mechanisms for these two processes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10413505     DOI: 10.1021/bi9902236

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  9 in total

1.  CK2 phosphorylation of an acidic Ser/Thr di-isoleucine motif in the Na+/H+ exchanger NHE5 isoform promotes association with beta-arrestin2 and endocytosis.

Authors:  Viktoria Lukashova; Elöd Z Szabó; Tushare Jinadasa; Alexei Mokhov; David W Litchfield; John Orlowski
Journal:  J Biol Chem       Date:  2011-02-04       Impact factor: 5.157

Review 2.  Regulation of protease-activated receptor signaling by post-translational modifications.

Authors:  Neil Grimsey; Antonio G Soto; JoAnn Trejo
Journal:  IUBMB Life       Date:  2011-03-24       Impact factor: 3.885

3.  Neuroinflammation-Induced Interactions between Protease-Activated Receptor 1 and Proprotein Convertases in HIV-Associated Neurocognitive Disorder.

Authors:  WooJin Kim; Erin Zekas; Robert Lodge; Delia Susan-Resiga; Edwidge Marcinkiewicz; Rachid Essalmani; Koichiro Mihara; Rithwik Ramachandran; Eugene Asahchop; Benjamin Gelman; Éric A Cohen; Christopher Power; Morley D Hollenberg; Nabil G Seidah
Journal:  Mol Cell Biol       Date:  2015-08-17       Impact factor: 4.272

4.  Regulation of CB1 cannabinoid receptor internalization by a promiscuous phosphorylation-dependent mechanism.

Authors:  Tanya L Daigle; Mary Lee Kwok; Ken Mackie
Journal:  J Neurochem       Date:  2008-07-01       Impact factor: 5.372

5.  HIV-induced neuroinflammation: impact of PAR1 and PAR2 processing by Furin.

Authors:  Vatsal Sachan; Robert Lodge; Koichiro Mihara; Josée Hamelin; Christopher Power; Benjamin B Gelman; Morley D Hollenberg; Éric A Cohen; Nabil G Seidah
Journal:  Cell Death Differ       Date:  2019-01-25       Impact factor: 15.828

6.  A rapid fluorogenic GPCR-β-arrestin interaction assay.

Authors:  Qiang Zhang; Yao-Wu Zheng; Shaun R Coughlin; Xiaokun Shu
Journal:  Protein Sci       Date:  2018-02-23       Impact factor: 6.725

7.  Unproductive cleavage and the inactivation of protease-activated receptor-1 by trypsin in vascular endothelial cells.

Authors:  Tetsuzo Nakayama; Katsuya Hirano; Yoshinobu Shintani; Junji Nishimura; Akio Nakatsuka; Hirotaka Kuga; Shosuke Takahashi; Hideo Kanaide
Journal:  Br J Pharmacol       Date:  2003-01       Impact factor: 8.739

8.  Gradient-dependent inhibition of stimulatory signaling from platelet G protein-coupled receptors.

Authors:  Ankit S Macwan; Niklas Boknäs; Maria P Ntzouni; Sofia Ramström; Jonathan M Gibbins; Lars Faxälv; Tomas L Lindahl
Journal:  Haematologica       Date:  2019-01-10       Impact factor: 9.941

Review 9.  Activated protein C, protease activated receptor 1, and neuroprotection.

Authors:  John H Griffin; Berislav V Zlokovic; Laurent O Mosnier
Journal:  Blood       Date:  2018-06-04       Impact factor: 25.476

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.